Author: Ryan Holtz

Ryan Holtz is a Senior Editor at Tech Insider covering Technology & Services sector stocks. His coverage universe includes Chinese Internet stocks in the eCommerce and online video sectors, Chinese online games stocks, as well as education companies. Holtz previously lived in Hong Kong for four years where he served in a dual role as head of Piper Jaffray Asia equity research and senior research analyst covering Chinese stocks. Before joining TI, Ryan was a management consultant at Deloitte & Touche LLC, where he worked in the financial services group.
Finance

Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T), Rosetta Genomics (NASDAQ:ROSG), The Buckle, Inc. (NYSE:BKE), ReneSola Ltd. (NYSE:SOL)

On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.11) by $0.14. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is -0.48%. On last trading day company shares ended up $4.18. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is … Continue reading Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T), Rosetta Genomics (NASDAQ:ROSG), The Buckle, Inc. (NYSE:BKE), ReneSola Ltd. (NYSE:SOL)

Ryan Holtz
Finance

Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

On 7 AUG OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced second quarter 2014 financial results. Revenue for the three and six months ended June 30, 2014 was $4.9 million and $16.7 million, respectively.  This compares with $6.3 million and $11.4 million, respectively, in the same periods in 2013. Revenue earned in the second quarter of 2014 consists of reimbursable clinical trial, manufacturing and preclinical costs incurred by … Continue reading Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

Ryan Holtz
Finance

Best Stocks: Oracle (NYSE:ORCL), Barrick Gold (NYSE:ABX), Viggle Inc. (NASDAQ:VGGL), REX American Resources Corporation (NYSE:REX), Bluelinx Holdings Inc. (NYSE:BXC)

The state of Oregon filed a lawsuit against Oracle Corporation (ORCL), in Marion County Circuit Court in Salem, seeking $200 million in damages from the tech company for failing to provide a functional health insurance exchange website. The state has also accused Oracle of making false statements and claims regarding the website. Oracle Corporation (NYSE:ORCL) belongs to Technology sector. Its net profit margin is 28.60% … Continue reading Best Stocks: Oracle (NYSE:ORCL), Barrick Gold (NYSE:ABX), Viggle Inc. (NASDAQ:VGGL), REX American Resources Corporation (NYSE:REX), Bluelinx Holdings Inc. (NYSE:BXC)

Ryan Holtz
Finance

Big Movers: Synacor (NASDAQ:SYNC), Silicon Laboratories (NASDAQ:SLAB), Beacon Roofing Supply (NASDAQ:BECN), Video Display Corporation (NASDAQ:VIDE), Ametek Inc. (NYSE:AME)

On 12 AUG Synacor, Inc. (NASDAQ:SYNC) announced its financial results for the second quarter of 2014. For the second quarter of 2014, total revenue was $24.2 million, compared to $26.7 million in the second quarter of 2013. Search and display advertising revenue was $18.5 million, compared to $21.4 million in the second quarter of 2013. Subscription-based revenue was $5.7 million, compared to $5.3 million in … Continue reading Big Movers: Synacor (NASDAQ:SYNC), Silicon Laboratories (NASDAQ:SLAB), Beacon Roofing Supply (NASDAQ:BECN), Video Display Corporation (NASDAQ:VIDE), Ametek Inc. (NYSE:AME)

Ryan Holtz
Finance

Today’s Hot List: NovaBay Pharmaceuticals (NYSEMKT:NBY), IHS (NYSE:IHS), Solitario Exploration (NYSEMKT:XPL), CIRCOR International, (NYSE:CIR), Hersha (NYSE:HT)

On July 31,2014 NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infectives, today reported second quarter 2014 financial results and provided a clinical and commercialization update. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) belongs to Healthcare sector. Its weekly performance is 22.55%. On last trading day company shares ended up $1.25. NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) distance from 50-day simple … Continue reading Today’s Hot List: NovaBay Pharmaceuticals (NYSEMKT:NBY), IHS (NYSE:IHS), Solitario Exploration (NYSEMKT:XPL), CIRCOR International, (NYSE:CIR), Hersha (NYSE:HT)

Ryan Holtz
Finance

Morning Buzz: Activision Blizzard (NASDAQ:ATVI), Altria (NYSE:MO), Tofutti Brands (NYSEMKT:TOF), Karyopharm Therapeutics, Inc. (NASDAQ:KPTI), ICICI Bank Ltd. (NYSE:IBN)

Activision Blizzard, Inc. (NASDAQ: ATVI) reported Q2 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $658 million versus the consensus estimate of $607.75 million. Activision Blizzard, Inc. (NASDAQ:ATVI) belongs to Technology sector. Its net profit margin is 29.10% and weekly performance is -2.61%. On last trading day company shares ended up $22.36. Activision Blizzard, Inc. (NASDAQ:ATVI) … Continue reading Morning Buzz: Activision Blizzard (NASDAQ:ATVI), Altria (NYSE:MO), Tofutti Brands (NYSEMKT:TOF), Karyopharm Therapeutics, Inc. (NASDAQ:KPTI), ICICI Bank Ltd. (NYSE:IBN)

Ryan Holtz